showed a trendP = 0.05
Ultimately, LLII MOTS-c treatment showed a trend towards increased median (6.4%) and maximum (7.0%) lifespan and reduced hazard ratio (0.654); P = 0.05 until 31.8 months (Fig. 4m ).
Ultimately, LLII MOTS-c treatment showed a trend towards increased median (6.4%) and maximum (7.0%) lifespan and reduced hazard ratio (0.654); P = 0.05 until 31.8 months (Fig. 4m ).